BioXcel Therapeutics Reports Second Quarter 2020 Financial Results and Provides Business Update

Go back to BioXcel Therapeutics Reports Second Quarter 2020 Financial Results and Provides Business Update

BioXcel Therapeutics (BTAI) Reports Q2 Loss of $1.06/sh

August 14, 2020 7:04 AM EDT

BioXcel Therapeutics (NASDAQ: BTAI) reported Q2 EPS of ($1.06), versus ($0.54) reported last year.

For earnings history and earnings-related data on BioXcel Therapeutics (BTAI) click here.

... More